Citations

Clear

6266 citation(s) found for "Ip, Andrew".

Miv-cel CD19 CAR T-Cell Therapy Shows Efficacy and Safety in Stiff Person Syndrome in a Pivotal, Multicenter, Phase 2 Study (KYSA-8) (LS2.008)
Ζεκερίδου, Αναστασία , Gutman, Jonathan, Lowe, Mallory, Eggmann, Sadie, McKeon, Andrew, Pittock, Sean J., Yi, Jessica J., Newsome, Scott D., Chou, Justin, Blarcom, Tom Van, Han, Xue, Sun, John, Sengupta, Shouvonik , Tooker, Ryan, Mehta, Aditi, Grayson, Dena , Gehchan, N., Piquet, Amanda L. , Gergis, Usama , Gutman, Jonathan A. , Kenderian, Saad S. , McKeon, Andrew , Pittock, Sean J. , Rakočević, Goran , Dalakas, Marinos C.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217905 Get It

Myelin Alterations Within and Beyond Lesions in MOG Antibody-associated Disease: Insights from Ultra-high field (7T) MRI (S6.002)
Fagan, Andrew, Port, John, Morris, Pearse, Chen, John, Tobin, W., Pittock, Sean, Tillema, Jan-Mendelt, Flanagan, Eoin , Cacciaguerra, Laura , Fagan, Andrew, Port, John D. , Pittock, Sean J. , Tillema, Jan‐Mendelt , Flanagan, Eoin P.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000217390 Get It

Calmodulin Kinase-like Vesicle-associated Protein (CAMKV) Autoimmune Encephalitis: Neurological & Oncological Accompaniments, Treatments, & Outcomes (S30.005)
Anissian, Diana, Gilligan, Michael , Carlson, Alise, Hogge, Christopher, Bael, Timothy, Dubey, Divyanshu, Mills, John, Pittock, Sean, Ζεκερίδου, Αναστασία , McKeon, Andrew, Carlson, Alise K. , Dubey, Divyanshu , Pittock, Sean J. , McKeon, Andrew

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000216000 Get It

Effectiveness of Infliximab for Refractory Non-ischemic Cerebral Enhancing Foreign-body Granulomatous Lesions Following Endovascular Therapy (P1-1.003)
Taha, Farris, Tagg, Nathan, Smith, Andrew, Flanagan, Eoin , Brown, Robert, Pittock, Sean, Perez-Giraldo, Gina, McKeon, Andrew, Aboseif, Albert , Taha, Farris , Tagg, Nathan T. , Flanagan, Eoin P. , Pittock, Sean J. , Perez-Giraldo, Gina , McKeon, Andrew

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215791 Get It

Autoantibody Profiling of Paraneoplastic Neurological Syndrome Sera Reveals ERVK7-IgG as a Germ Cell Tumor Associated Biomarker (S16.002)
Hammami, M Bakri, Knight, Andrew, Costello, Brian, DeLorenzo, Silvana, Leibovich, Bradley, Cheville, John, Guo, Yong, Sagen, Jessica, olson, Janet, Pittock, Sean, Mills, John, Dasari, Surendra, Dubey, Divyanshu, Kherbek, Haidara , Bakri, Hammami M , Knight, Andrew, Costello, Brian A. , Leibovich, Bradley C. , Cheville, John, Algeciras‐Schimnich, Alicia , Pittock, Sean J. , DASARI, SURENDRA, Dubey, Divyanshu

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215272 Get It

Safety and Tolerability of GTX-104 (Nimodipine Injection for IV Infusion) Compared With Oral Nimodipine in Patients With Aneurysmal Subarachnoid Hemorrhage: A Prospective, Randomized Trial (S21.001)
Macdonald, Loch, Choi, Huimahn, Chou, Sherry, Ducruet, Andrew, Kimberly, W Taylor, Rabinstein, Alejandro, Chou, Sherry, Kimberly, William Taylor , Rabinstein, Alejandro A.

Mayo Clinic

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215398 Get It

Value of Inpatient Clinical Pharmacists
Dumont, Zack , Alhammad, Abdullah M., Dager, William E. , Edwards, Megan E. , Higgins, Tara, Miesner, Andrew R. , Pon, Tiffany , Rech, Megan A. , Yoby, Alexandra , Alhammad, Abdullah , Dumont, Zachary J. , Edwards, Megan , Rogers, Kelly C , Alhammad, Abdullah M , Coons, James C , Dager, William E , Edwards, Megan E , Miesner, Andrew R , Pon, Tiffany , Rech, Megan A , Yoby, Alexandria G

Mayo Clinic

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | June 6, 2026 | Volume: 9 | Issue: 6 | Pages: No page available

10.1002/jac5.70230 | PMID 42249604 Get It

ABSTRACT Inpatient, acute care clinical pharmacists have contributed to many notable improvements in patient outcomes. Several studies have shown a reduction in mortality and other clinical markers when pharmacists are integrated within the care team. Economic analyses of inpatient clinical pharmacy services (CPS) generally demonstrate cost savings related to specific medication classes, prevention of adverse drug events, decreased length of stay, and decreased rehospitalization. Studies also show high satisfaction from other health care professionals, noting improvements in medication‐related patient safety. Finally, studies conducted in tertiary care hospital settings report high levels of patient satisfaction with CPS. As such, the ECHO framework, based on economic, clinical, and humanistic outcomes, is used herein to organize the summary of literature associated with CPS. Given the growing body of evidence, numerous health professional and government organizations recognize the role of pharmacists as an integral part of the inpatient team. Yet implementation of CPS has not been fully realized by hospitals and health systems. This paper briefly describes inpatient CPS, highlights many benefits of and endorsements for clinical pharmacist participation on interdisciplinary teams, and provides high‐level recommendations for health system administrators and the profession of pharmacy to further encourage broader integration of CPS into patient care teams. Effectively positioning inpatient clinical pharmacists as indispensable team members will require intentional work and strategic planning with a focus on high‐impact value, visibility, and leadership.